About PGHAX
Putnam Global Health Care Fund Class R6 is an open-end mutual fund specializing in the global healthcare sector. Its core objective is capital appreciation, achieved through active investment primarily in common stocks of large and midsize healthcare companies worldwide. The fund employs a research-driven approach that combines deep fundamental analysis with technical assessment, allowing it to identify and invest in companies engaged in scientific innovation, pharmaceuticals, biotechnology, medical equipment, and related health services. While the majority of assets are allocated to U.S.-based firms, a significant portion targets international healthcare opportunities, with over 20% invested in foreign equities. Distinct from diversified funds, Putnam Global Health Care Fund Class R6 holds a concentrated portfolio, with its top ten holdings making up over half of its total assets. The fund’s non-diversified structure enables focused exposure to sector trends and advancements, while regular monitoring aims to capitalize on emerging opportunities. Its expense ratio is competitive relative to peers, and it distributes dividends annually. Overall, this fund serves as a specialized vehicle for investors seeking targeted participation in the evolving global healthcare industry.
Fund Family Franklin Templeton Investments
Category Health
Performance Rating Above Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol PGHAX
Index MSCI World/Health Care NR
PGHAX had a total return of 24.78% in the past year, including dividends. Since the fund's
inception, the average annual return has been 10.03%.
